“Early Phase I Results for 4-Demethyl-4-cholesteryloxypenclo-medine [DM-CHOC-PEN] as Therapy in Adolescent and Young Adult (AYA) Subjects with Advanced Malignancies ”, J. Can. Res. Updates, vol. 7, no. 3, pp. 75–78, Aug. 2018, doi: 10.6000/1929-2279.2018.07.03.2.